Key facts
- This page summarizes Halley E. Gilbert's Form 4 filing for Arcutis Biotherapeutics, Inc. (ARQT).
- 2 reported transactions and 1 derivative row are listed below.
- Accepted by SEC: 03 Jun 2022, 16:56.
Halley E. Gilbert - 01 Jun 2022 Form 4 Insider Report for Arcutis Biotherapeutics, Inc. (ARQT)
- Form type
- 4
- Accepted by SEC
- 03 Jun 2022, 16:56:16 UTC
- Previous filing
- 03 Mar 2022
- Next filing
- 17 Jun 2022
- SEC filing
- View on sec.gov
- Reporting owner signature
- /s/ Scott Burrows, as Attorney-in-Fact for Halley E. Gilbert
Source evidence
5 source fields
Reporting owner
1 detail
Key filing fact
Halley E. Gilbert filed Form 4 for Arcutis Biotherapeutics, Inc. (ARQT) on 03 Jun 2022.
Change
- Previous filing in this sequence was filed on 03 Mar 2022.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
See Original Filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
ARQT
transaction
Common Stock
Award
- Transaction value
- $0
- Shares
- +4,312
- Change %
- Price
- $0.000000
- Shares after
- 4,312
- Date
- 01 Jun 2022
- Ownership
- Direct
- Footnotes
- F1
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
ARQT
transaction
Derivative
Stock Option (Right to Buy)
Award
- Transaction value
- $0
- Shares
- +11,796
- Change %
- Price
- $0.000000
- Shares after
- 11,796
- Date
- 01 Jun 2022
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 11,796
- Exercise price
- $20.29
- Footnotes
- F2
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 2 footnotes
Footnote F1
Includes 4,312 Restricted Stock Units ("RSUs"). The Reporting Person is entitled to receive one (1) share of common stock for each one (1) RSU upon the vesting thereof.
Footnote F2
The underlying shares subject to the option vest and become exercisable as to 100% on the first anniversary of June 1, 2022.